BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 22321375)

  • 1. A grand scale challenge: vaccine discovery for helminth control in definitive hosts.
    Piedrafita D; Matthews JB
    Parasite Immunol; 2012 May; 34(5):241-2. PubMed ID: 22321375
    [No Abstract]   [Full Text] [Related]  

  • 2. Phage-display library biopanning as a novel approach to identifying nematode vaccine antigens.
    Ellis SE; Newlands GF; Nisbet AJ; Matthews JB
    Parasite Immunol; 2012 May; 34(5):285-95. PubMed ID: 21770973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Progress in the development of vaccines against helminths].
    Kozak M; Kołodziej-Sobocińska M
    Wiad Parazytol; 2009; 55(2):147-56. PubMed ID: 19670530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination against helminth parasite infections.
    Hewitson JP; Maizels RM
    Expert Rev Vaccines; 2014 Apr; 13(4):473-87. PubMed ID: 24606541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blunting the knife: development of vaccines targeting digestive proteases of blood-feeding helminth parasites.
    Pearson MS; Ranjit N; Loukas A
    Biol Chem; 2010 Aug; 391(8):901-11. PubMed ID: 20482309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant expression systems: the obstacle to helminth vaccines?
    Geldhof P; De Maere V; Vercruysse J; Claerebout E
    Trends Parasitol; 2007 Nov; 23(11):527-32. PubMed ID: 17945533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perspective: prospects for development of vaccines against human helminth infections.
    McCarthy JS; Nutman TB
    J Infect Dis; 1996 Dec; 174(6):1384-90. PubMed ID: 8940241
    [No Abstract]   [Full Text] [Related]  

  • 8. Extracellular vesicles: new targets for vaccines against helminth parasites.
    Drurey C; Coakley G; Maizels RM
    Int J Parasitol; 2020 Aug; 50(9):623-633. PubMed ID: 32659278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promising Technologies in the Field of Helminth Vaccines.
    Perera DJ; Ndao M
    Front Immunol; 2021; 12():711650. PubMed ID: 34489961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccines against veterinary helminths.
    Hein WR; Harrison GB
    Vet Parasitol; 2005 Sep; 132(3-4):217-22. PubMed ID: 16095841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helminth vaccines.
    McManus DP
    Biotechnology; 1992; 20():99-128. PubMed ID: 1600391
    [No Abstract]   [Full Text] [Related]  

  • 12. Marc Kirschner. Interview by Asher Mullard.
    Kirschner M
    Nat Rev Drug Discov; 2011 Dec; 10(12):894. PubMed ID: 22129982
    [No Abstract]   [Full Text] [Related]  

  • 13. Systems biology in the development of HIV vaccines.
    Haddad EK; Pantaleo G
    Curr Opin HIV AIDS; 2012 Jan; 7(1):44-9. PubMed ID: 22156842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel immunomic technologies for schistosome vaccine development.
    McWilliam HE; Driguez P; Piedrafita D; McManus DP; Meeusen EN
    Parasite Immunol; 2012 May; 34(5):276-84. PubMed ID: 22486551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [System biology and synthetic biology modify drug discovery and development].
    Haiech J; Ranjeva R; Kilhoffer MC
    Med Sci (Paris); 2012 Feb; 28(2):207-12. PubMed ID: 22377310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in helminth immunology: optimism for future vaccine design?
    Harris NL
    Trends Parasitol; 2011 Jul; 27(7):288-93. PubMed ID: 21531626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developments and hurdles in generating vaccines for controlling helminth parasites of grazing ruminants.
    Smith WD; Zarlenga DS
    Vet Parasitol; 2006 Jul; 139(4):347-59. PubMed ID: 16750599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fasciola hepatica: an antigen fraction derived from newly excysted juveniles, containing an immunoreactive 32-kDa protein, induces strong protective immunity in rats.
    van Milligen FJ; Cornelissen JB; Bokhout BA
    Exp Parasitol; 2000 Mar; 94(3):163-71. PubMed ID: 10831381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunity and vaccine control of Echinococcus granulosus infection in animal intermediate hosts.
    Lightowlers MW; Heath DD
    Parassitologia; 2004 Jun; 46(1-2):27-31. PubMed ID: 15305682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overcoming limitations in the systems vaccinology approach: a pathway for accelerated HIV vaccine development.
    Zak DE; Aderem A
    Curr Opin HIV AIDS; 2012 Jan; 7(1):58-63. PubMed ID: 22156843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.